Altogether, in AML and possibly in CML, the level of HGF in serum strongly correlates with biological parameters considered to reflect tumoural burden, especially leukocyte counts, splenomegaly and vascular syndrome. This evidence concerns the gene HGF and chronic myelogenous leukemia, BCR-ABL1 positive.